Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Income from Continuing Operations: 2012-2025

Historic Income from Continuing Operations for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $108.6 million.

  • CorMedix's Income from Continuing Operations rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
  • Per CorMedix's latest filing, its Income from Continuing Operations stood at $108.6 million for Q3 2025, which was up 433.49% from $20.3 million recorded in Q2 2025.
  • CorMedix's Income from Continuing Operations' 5-year high stood at $108.6 million during Q3 2025, with a 5-year trough of -$14.5 million in Q1 2024.
  • Its 3-year average for Income from Continuing Operations is $10.0 million, with a median of -$6.3 million in 2023.
  • Per our database at Business Quant, CorMedix's Income from Continuing Operations slumped by 60.27% in 2023 and then surged by 4,002.28% in 2025.
  • Over the past 5 years, CorMedix's Income from Continuing Operations (Quarterly) stood at -$7.8 million in 2021, then dropped by 5.36% to -$8.2 million in 2022, then plummeted by 42.18% to -$9.7 million in 2023, then surged by 71.45% to $13.5 million in 2024, then skyrocketed by 4,002.28% to $108.6 million in 2025.
  • Its last three reported values are $108.6 million in Q3 2025, $20.3 million for Q2 2025, and $20.6 million during Q1 2025.